Browsing: Feature Stories
Primary Bioscience is betting that single-molecule protein sequencing — not genomics — is the key to making multi-cancer early detection…
For the roughly 300 million people worldwide living with a rare disease, the path to diagnosis has historically looked less…
Imagine waking up after five months of deep sleep — your heart beating just a handful of times per minute,…
Spinal fusion is one of the most performed surgical interventions in the United States, yet the core mechanics of its…
For half a century, the dominant assumption in cell biology has been that understanding a cell requires marking it —…
Artificial intelligence in drug discovery is no longer evaluated on novelty alone. The industry’s center of gravity has shifted toward…
Two years ago, circular RNA was still easy to dismiss as a niche. In 2026, it’s harder — partly because…
For more than a decade, the biotech industry has chased a seductive idea: that drug discovery could be transformed from…
A marker-less approach to knee robotics is reframing a crowded field — and raising a bigger question about whether the…
From Intra-Cellular Therapies and Celmatix to Evvy, Gameto, Concarlo, and Twentyeight Health, six companies delivered FDA progress, clinical evidence, and…